Similarly the ectopic expression of CXCR1, which is not normally expressed on T cells, or CXCR2, on anti-CD70 CAR T cells, enhanced the trafficking to tumours and elicited tumour regression and improved survival in models of glioblastoma, pancreatic cancer, and ovarian cancer [38]. The gene discussed is CXCR2; the disease is neoplasm.